Myasthenia gravis induced by pembrolizumab in a patient with metastatic Merkel cell carcinoma

被引：1
|
作者：
Pottier, C. [1 ]
El Habnouni, C. [1 ]
Kervarrec, T. [2 ,3 ]
Beltran, S. [4 ]
Samimi, M. [1 ,3 ]
机构：
[1] CHRU Tours, Dept Dermatol, Hosp Trousseau, Ave Republ, F-37044 Tours 9, France
[2] CHRU Tours, Dept Pathol, F-37044 Tours 9, France
[3] Univ Tours, INRA, ISP 1282, F-37000 Tours, France
[4] CHRU Tours, Dept Neurol, F-37044 Tours 9, France
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2022年 / 149卷 / 02期
关键词：
Myasthenia gravis; Immune checkpoint inhibitors; Pembrolizumab; Immune adverse event;
D O I：
10.1016/j.annder.2022.01.002
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：142 / 145
页数：4
相关论文
共 50 条
  • [1] Outcome of patient with myasthenia gravis with the use of immunotherapy in metastatic Merkel cell carcinoma
    Williams, Sarah
    Liang, Christina
    Guminski, Alexander
    Hruby, George
    Chan, David
    OXFORD MEDICAL CASE REPORTS, 2022, 2022 (02): : 67 - 70
  • [2] Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma
    Nozomi Hayakawa
    Eiji Kikuchi
    Shigeaki Suzuki
    Mototsugu Oya
    International Cancer Conference Journal, 2020, 9 : 123 - 126
  • [3] Myasthenia gravis with myositis induced by pembrolizumab therapy in a patient with metastatic urothelial carcinoma
    Hayakawa, Nozomi
    Kikuchi, Eiji
    Suzuki, Shigeaki
    Oya, Mototsugu
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2020, 9 (03) : 123 - 126
  • [4] Pembrolizumab-Associated Seronegative Myasthenia Gravis in a Patient With Metastatic Renal Cell Carcinoma
    Pandya, Shaunak K.
    Ulrickson, Matthew
    Dong, JiaXi
    Willen, Ryan
    Pandya, Arati
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [5] Pembrolizumab-Induced Myasthenia Gravis With Myocarditis in the Setting of Metastatic Renal Cell Carcinoma
    Taboada, Phillip
    Lee, Matthew
    Hoyer, Remington
    Gray, Zane
    Wang, Jue
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [6] A Case of Pembrolizumab-Induced Myasthenia Gravis in a Patient with Squamous Cell Lung Carcinoma
    Nemeh, C. N.
    Wayant, C.
    Padgett, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [7] Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
    Zaremba, Anne
    Chorti, Eleftheria
    Jockenhoefer, Finja
    Bolz, Saskia
    Sirin, Selma
    Glas, Martin
    Becker, Juergen C.
    Ugurel, Selma
    Boesch, Alexander
    Schadendorf, Dirk
    Livingstone, Elisabeth
    Hagenacker, Tim
    Zimmer, Lisa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [8] Paraneoplastic myasthenia gravis associated with Merkel cell carcinoma
    Lankenau Vela, D. L.
    Decanini Arcaute, H.
    De la Garza Salazar, F.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2019, 27 (03): : 131 - 135
  • [9] Pembrolizumab Induced Myasthenia Gravis
    Wu, D.
    Condit, D.
    Nascimento, J. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [10] A case report of nivolumab-induced myasthenia gravis and myositis in a metastatic renal cell carcinoma patient
    Nakanishi, Shotaro
    Nishida, Sho
    Miyazato, Minoru
    Goya, Masato
    Saito, Seiichi
    UROLOGY CASE REPORTS, 2020, 29
12345